Comerica Bank
BBC icon

Comerica Bank’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Comerica Bank’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35
Closed -$884 – 3679
2024
Q2 		$884 Sell
35
-248
-88% -$6.62K ﹤0.01% 3593
2024
Q1 		$8.24K Buy
+283
New +$7.76K ﹤0.01% 3223

Other funds holding BBC

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Federation des caisses Desjardins du Quebec
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Dynamic Wealth Strategies
Dynamic Wealth Strategies Granite Bay, California $188M AUM 12.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Harbour Investments
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
Baldwin Wealth Partners
Baldwin Wealth Partners Marion, Massachusetts $1.52B AUM 21.45% 1-Year Est. Return

Comerica Bank's BBC Position: Q3 2024 in Review

Comerica Bank sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q3 2024, closing a stake of 35 shares — an estimated $884 sold.

Comerica Bank first reported a position in BBC in Q1 2024 and held it in 2 quarters. The position peaked at $8.24K in Q1 2024. 13 funds tracked by Wall St. Rank hold BBC as of Q3 2024.

  • Comerica Bank reported no remaining Virtus Biotech Clinical Trials ETF position as of Q3 2024 after selling out during the quarter.
  • Comerica Bank sold 35 Virtus Biotech Clinical Trials ETF shares in Q3 2024, an estimated $884.
  • Comerica Bank first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2024 and held it in 2 quarters.
  • Comerica Bank's Virtus Biotech Clinical Trials ETF position peaked at $8.24K in Q1 2024.
  • 13 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2024.

Based on Comerica Bank's 13F filing for Q3 2024, filed 14 Nov 2024.